About
Dr Claudia Bruedigam is a Research Scientist with a major interest in blood cancers. She leads the Leukaemia Metabolism Laboratory at QIMR Berghofer Medical Research Institute, and serves as Honorary Senior Fellow at The University of Queensland, Brisbane, Australia. Following undergraduate studies in Biochemistry with specialisation in Metabolomics at University of Potsdam in Germany, Claudia received her PhD in Molecular Medicine from Erasmus University Rotterdam, The Netherlands, in June 2015. Her PhD studies were supported by a competitive European Marie Curie Mobility Fellowship. Since 2019, Claudia has developed her research program with the support of >$1.5M funding from sole chief investigator NHMRC grants, and a Play for a Cure Foundation donation. She has received numerous awards including prestigious ASH Abstract Achievement Awards in 2013, 2016, and 2017, and a Leukaemia Foundation New Investigator Award in 2014. Claudia has demonstrated expertise with a track record of at least 27 peer-reviewed publications including first and corresponding author publications in the top international journals Cell Stem Cell and Nature Cancer.
Research Skills
Human in vivo and in vitro AML modelling, patient-derived xenograft trials, functional genetics, metabolomics, transcriptomics, integrative analyses
Area of Interest
Acute myeloid leukaemia (AML), haematopoiesis, leukaemia stem cells, cancer metabolism, telomere biology